Tag: Health Care

Displaying 581 - 600 of 811 results.

Testifying on behalf of the Federal Trade Commission today before the U.S. Senate Judiciary Committee, Chairman Timothy J. Muris provided the FTC’s perspective on current marketplace issues involving consumer access to generic pharmaceuticals. The Chairman also presented results from the...
A nonprofit corporation representing approximately 1,000 participating physicians in the Dallas/Fort Worth, Texas metropolitan area has agreed to settle Federal Trade Commission charges that collective bargaining on behalf of its members has led to decreased competition and increased prices for...
The Federal Trade Commission and Department of Justice today released an agenda for a session of their joint hearings on health care and competition law and policy to be held June 25-26, 2003. These hearings will be held at the FTC Conference Center at 601 New Jersey Avenue, N.W., Washington, DC....
The Federal Trade Commission and Department of Justice (DOJ) today released a detailed schedule for the sessions of their joint hearings on health care and competition law and policy to be held June 10-12, 2003. These hearings will be held at the FTC Conference Center at 601 New Jersey Avenue, N.W...
Two San Diego County, California, anesthesiologists groups have agreed to settle Federal Trade Commission charges that they jointly agreed on certain fees and other competitively significant terms that they would demand from Grossmont Hospital for providing on-call services. The two groups,...
The Federal Trade Commission and Department of Justice today released a detailed schedule for the sessions of their joint hearings on health care and competition law and policy to be held May 27, 2003 and May 29-30, 2003. These hearings will be held at the FTC Conference Center at 601 New Jersey...
A New Mexico physician organization settled charges that it and its members entered into agreements to fix prices and to refuse to deal with third party payers and other health care plans except on collectively agreed-upon terms.
The Federal Trade Commission and Department of Justice today released a revised schedule for the sessions of their joint hearings on health care and competition law and policy originally scheduled for May 21-23 and May 29-30. The hearings will now be held May 27-30 and June 10-12 at the FTC...
The fourth session of the Federal Trade Commission/Department of Justice joint hearings on health care and competition law and policy will begin on Wednesday, April 23, 2003, at 9:15 a.m. The hearings will be held daily on April 23, 24, and 25 from 9:15 a.m. to 5:00 p.m. in the FTC Conference...
A final consent order permits Pfizer Inc.'s acquisition of Phamacia Corporation while requiring the divestiture of various products including extended release drugs used in the treatment of an overactive bladder; hormone replacement therapies; erectile dysfunction; canine arthritis;...
Pfizer Inc., and Pharmacia Corporation will divest pharmaceutical products in nine separate product markets to different third parties to settle Federal Trade Commission charges that the merger of Pharmacia and Pfizer likely would have anticompetitive effects in those product markets and violate...
The Federal Trade Commission and Department of Justice today released a detailed schedule listing specific witnesses for the sessions of their joint hearings on health care and competition law and policy to be held April 23 - 25 and May 7 - 8, 2003. These hearings will be held at the FTC...
The third session of the Federal Trade Commission/Department of Justice joint hearings on health care and competition law and policy will begin on Wednesday, April 9 at 2:00 p.m. The agenda for the session is available at http://www.ftc.gov/ogc/healthcarehearings/ and athttp://www.usdoj.gov/atr/...
United States Attorney Michael J. Sullivan, Assistant Attorney General Robert D. McCallum, Jr., and Federal Trade Commission Bureau of Competition Director Joe Simons announced today that a federal judge has fined Boston Scientific Corporation (BSC) more than $7 million for violating an FTC order...
  The Federal Trade Commission and the Department of Justice today released a detailed schedule for the sessions of their joint hearings on health care and competition law and policy to be held April 9-11, 2003. These hearings will be held at the FTC Conference Center at 601 New Jersey Avenue, N.W...
The Federal Trade Commission and Department of Justice today released a detailed agenda for the sessions of their joint hearings on health care and competition law and policy to be held during April - May, 2003.
The second session of the Federal Trade Commission/Department of Justice joint hearings on health care and competition law and policy will begin on Wednesday, March 26 at 9:15 a.m. EST. The hearings will feature representatives of the FTC, the DOJ, the Department of Health & Human Services,...
The Federal Trade Commission (FTC) and the Department of Justice (DOJ) today released a detailed schedule for the sessions of their joint hearings on health care and competition law and policy to be held March 26-28, 2003. These hearings will be held at the FTC Conference Center at 601 New Jersey...
The Commission has received a petition from Solvay S.A.
Bristol-Myers Squibb Company (BMS) settled charges that it engaged in illegal business practices to delay the entry of three low price generic pharmaceuticals that would be in direct competition with three of its branded drugs. The complaint alleged that BMS purposely made wrongful...

Pages